drugset / Trial / NCT05507489

Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection

NCT05507489 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Jinzhen oral liquid and Jinhuaqinggan Granules were used in the treatment and the control group for 14 days, respectively, to evaluate the effect of Jinzhen oral liquid in treating children with novel coronavirus infection.

Timeline

Start
2022-03-18
Primary completion
2022-09-10
Completion
2023-03-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Jinhuaqinggan granules Unknown — —
Subject Jinzhen oral liquid Unknown 10 ml Oral
Subject Jinzhen oral liquid Unknown 15 ml Oral

Indications